SCHEMBL30721019

SCHEMBL30721019

Cc1cc([C@@H](C)N)c2nc(N3CCC(C)CC3)n(C)c(=O)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 1/20 0.47
▸ AKT2 P31751 1/20 0.47
▸ AKT3 Q9Y243 1/20 0.47
▸ CRHR1 P34998 1/20 0.39
▸ TSHR P16473 4/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ RECQL P46063 1/20 0.35
▸ TP53 P04637 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ KDM1A O60341 4/20 0.33
▸ HSD17B10 Q99714 3/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ GAA P10253 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30783721 1.00 AKT1 (0.47) AKT1AKT2AKT3CRHR1TSHR
SCHEMBL30784055 0.90 AKT1 (0.48) AKT1AKT2AKT3CRHR1TSHR
SCHEMBL30783611 0.88 AKT1 (0.45) AKT1AKT2AKT3CRHR1KDM1A
SCHEMBL30783583 0.86 AKT1 (0.47) AKT1AKT2AKT3CRHR1KMT2A
SCHEMBL30784348 0.86 AKT1 (0.47) AKT1AKT2AKT3CRHR1KMT2A
SCHEMBL25360674 0.85 AKT1 (0.52) AKT1AKT2AKT3CRHR1PTPN11
SCHEMBL31538199 0.85 AKT1 (0.61) AKT1AKT2AKT3CRHR1PTPN11
SCHEMBL30690362 0.85 AKT1 (0.61) AKT1AKT2AKT3CRHR1PTPN11
SCHEMBL25360677 0.85 AKT1 (0.52) AKT1AKT2AKT3CRHR1PTPN11
SCHEMBL30495297 0.85 AKT1 (0.52) AKT1AKT2AKT3CRHR1PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024000401-A1 2-((1-(6-METHYL-4-OXO-3,4-DIHYDROQUINAZOLIN-8-YL)ETHYL)AMINO)BENZOIC ACID DERIVATIVES AND SIMILAR COMPOUNDS AS PI3K INHIBITORS FOR THE TREATMENT OF E.G. CANCER QILU REGOR THERAPEUTICS INC. (CN) 2024-01-04 — — WO disclosed
Send feedback